- Home
- PBYI vs AOMR Comparison
PBYI vs AOMR Comparison
Compare PBYI & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | AOMR |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 218.7M |
| IPO Year | 2011 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PBYI | AOMR |
|---|---|---|
| Price | $6.00 | $8.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.31 |
| AVG Volume (30 Days) | ★ 429.2K | 83.4K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 15.31% |
| EPS Growth | N/A | ★ 53.85 |
| EPS | 0.61 | ★ 1.80 |
| Revenue | ★ $27,685,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.83 |
| P/E Ratio | $9.84 | ★ $4.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.58 | $7.36 |
| 52 Week High | $7.68 | $10.21 |
Technical Indicators
Market Signals| Indicator | PBYI | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 40.67 |
| Support Level | $5.57 | $8.18 |
| Resistance Level | $6.15 | $8.91 |
| Average True Range (ATR) | 0.37 | 0.18 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 33.18 | 34.85 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.